Follow The Filings

CL Colgate-Palmolive

Consumer Staples, filed as COLGATE PALMOLIVE CO (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Sold by 2 managers in 2026 Q2

  • 1 Owner
  • #262
  • Max 0.5%
  • Master 0.05%
  • $1.3M
  • 1 reduce 1 exit

In 2026 Q3 Murphy Pohlad trimmed Colgate-Palmolive, and David Katz sold out.

Who owns this now

Largest portfolio weights among holders, up to 0.5% (Murphy Pohlad, Murphy Pohlad Asset Management). Not free-float ownership.

  1. Murphy Pohlad Reduce 0.46%

Who owns CL

Sorted by value, long equity only, as of 2026 Q3.

History
Murphy Pohlad, Murphy Pohlad Asset Management 0.46%, was 0.61% Reduce −19.2% 15,569 $1.3M History
David Katz, Matrix Asset Advisors exited 2026 Q3 Last 2026 Q2 0.02% Exit −0.02% 2,383 $218K History

1 current, 1 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by CL's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CL insider trades
  • None no insider bought on the open market
  • $57.1M sold by 8 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Panagiotis Tsourapas COO
    Sale
    $920K 10,000 shares at $92.05 13% of stake
    Traded Aug 24 Filed Aug 26
    ↗
  2. John T Cahill Director
    Sale
    $389K 4,170 shares at $93.37 13% of stake
    Traded Aug 6 Filed Aug 7
    ↗
  3. Noel R. Wallace CEO
    Sale
    $29.7M 322,042 shares at $92.22 47% of stake
    Traded Aug 4–5 Filed Aug 6
    ↗
  4. Gregory Malcolm EVP and Controller
    Sale
    $203K 2,300 shares at $88.44 15% of stake
    Traded May 15 Filed May 18
    ↗
  5. Sally Massey Chief People Officer
    Sale
    $752K 8,599 shares at $87.41 38% of stake
    Traded May 7 Filed May 11
    ↗
  6. Panagiotis Tsourapas COO
    Sale
    $4.8M 50,000 shares at $95.57 83% of stake
    Traded Feb 11–12 Filed Feb 13
    ↗
  7. John Hazlin Chief Growth Officer
    Sale
    $2M 20,989 shares at $94.25 54% of stake
    Traded Feb 10 Filed Feb 12
    ↗
  8. Gregory Malcolm EVP and Controller
    Sale
    $1.2M 12,747 shares at $94.91 52% of stake
    Traded Feb 6 Filed Feb 10
    ↗
  9. Sally Massey Chief Human Resources Officer
    Sale
    $1.5M 15,851 shares at $95.03 54% of stake
    Traded Feb 5 Filed Feb 9
    ↗
  10. Stanley J Sutula III CFO
    Sale
    $9.2M 97,843 shares at $94.27 64% of stake
    Traded Feb 4 Filed Feb 6
    ↗
  11. Jennifer Daniels CLO and Secretary
    Sale
    $2.1M 22,000 shares at $94.34 22% of stake
    Traded Feb 4 Filed Feb 6
    ↗
  12. Noel R. Wallace CEO
    Sale
    $4.3M 45,568 shares at $93.91 14% of stake
    Traded Feb 4 Filed Feb 6
    ↗
  13. Sally Massey Chief Human Resources Officer
    Sale
    $100K 1,237 shares at $80.89 8.3% of stake
    Traded Nov 21, 2025 Filed Nov 24, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 36 stock grants, 36 share withholdings for taxes, and 10 option exercises.

Congress

7 members of Congress traded CL in the last three years: 4 buys and 12 sales. 10 members listed it in 2025 annual reports.

All Congress trades
  1. Kevin Hern R-OK-1Joint Partial sale $1K–$15K Sep 2 filed Sep 25
  2. Kevin Hern R-OK-1 Sell $1K–$15K Aug 31 filed Sep 25
  3. Kevin Hern R-OK-1 Partial sale $1K–$15K Aug 27 filed Sep 25
  4. Kevin Hern R-OK-1Joint Sell $1K–$15K Aug 19 filed Sep 1
  5. Julie Johnson D-TX-32Joint Buy $1K–$15K Sep 23, 2025 filed Aug 5
  6. Julie Johnson D-TX-32Joint Sell $1K–$15K Sep 23, 2025 filed Aug 5

SEC filings

Recent issuer filings from EDGAR, 3 shown.

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc

Source: SEC EDGAR submissions, updated 26 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $19.46B $20.1B $20.38B
Gross profit $11.33B $12.16B $12.25B
Gross margin * 58.2% 60.5% 60.1%
Net income $2.3B $2.89B $2.13B
Net margin * 11.8% 14.4% 10.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $5.28B $5.32B $5.71B
Total non-current assets * $11.11B $10.73B $10.62B
Total assets $16.39B $16.05B $16.33B
Total current liabilities $4.74B $5.76B $6.85B
Total non-current liabilities * $10.7B $9.74B $9.11B
Total equity $609M $212M $54M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $3.74B $4.11B $4.2B
Cash from investing -$742M -$534M -$817M
Cash from financing -$2.79B -$3.39B -$3.26B
Net change in cash $191M $130M $192M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.